Delivery Order SPE2DB25D3201-SPE2DB25FNTYP

Award Date 6/16/25
Potential Completion Date 6/17/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a prescription medication. The contract has a ceiling value of $71,558.32 and a performance period through June 30, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a ceiling value of $6,450.30 and a performance period ending on May 19, 2025. The contract is not set aside and was awarded on May 16, 2025. Amerisourcebergen Drug Corp is the prime contractor and has no...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a ceiling value of $1,543.62. The contract is a firm fixed price delivery order with a completion date of June 16, 2025. This contract is not set aside and represents open competition. Amerisourcebergen Drug Corp is the prime contractor and...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with an ultimate completion date of May 16, 2025 and a ceiling value of $5,051.62. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a firm fixed price ceiling value of $8,321.48 and a performance period ending June 6, 2025. The contract is not set-aside and was awarded on June 5, 2025. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,406.21, is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product. The contract has a completion date of June 13, 2025 and is not a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a total ceiling value of $10,612.62 and a period of performance ending on May 22, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a ceiling value of $3,240.92 and a performance period ending on May 21, 2025. The contract is a Firm Fixed Price Delivery Order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a medication used for the treatment of respiratory conditions. The award has a ceiling value of $12,191.57 and a completion date of June 11, 2025. This delivery order is not associated with a set-aside program, indicating open...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, with a ceiling value of $2,111.34 and a period of performance through April 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNTYP
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a ceiling value of $11,121.27 and a period of performance through June 17, 2025. The contract is not set aside and was awarded on June 16, 2025. Amerisourcebergen Drug Corp is the prime contractor and there are no major subcontractors mentioned. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/15/25, 9:50 AM